167 related articles for article (PubMed ID: 33045961)
1. Do Mitochondrial DNA Mutations Play a Key Role in the Chronification of Sterile Inflammation? Special Focus on Atherosclerosis.
Orekhov AN; Gerasimova EV; Sukhorukov VN; Poznyak AV; Nikiforov NG
Curr Pharm Des; 2021; 27(2):276-292. PubMed ID: 33045961
[TBL] [Abstract][Full Text] [Related]
2. Possible Role of Mitochondrial DNA Mutations in Chronification of Inflammation: Focus on Atherosclerosis.
Orekhov AN; Nikiforov NN; Ivanova EA; Sobenin IA
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32244740
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations.
Orekhov AN; Ivanova EA; Markin AM; Nikiforov NG; Sobenin IA
Curr Atheroscler Rep; 2020 Aug; 22(10):54. PubMed ID: 32772280
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mitochondrial Mutations in Chronification of Inflammation: Hypothesis and Overview of Own Data.
Orekhov AN; Nikiforov NG; Omelchenko AV; Sinyov VV; Sobenin IA; Vinokurov AY; Orekhova VA
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013333
[TBL] [Abstract][Full Text] [Related]
6. Role of the mtDNA Mutations and Mitophagy in Inflammaging.
Dabravolski SA; Nikiforov NG; Zhuravlev AD; Orekhov NA; Grechko AV; Orekhov AN
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163247
[TBL] [Abstract][Full Text] [Related]
7. Defective Mitophagy Impairs Response to Inflammatory Activation of Macrophage-Like Cells.
Orekhov AN; Zhuravlev AD; Vinokurov AY; Nikiforov NG; Omelchenko AV; Sukhorukov VN; Sinyov VV; Sobenin IA
Curr Med Chem; 2024 Mar; ():. PubMed ID: 38441018
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis.
Salnikova D; Orekhova V; Grechko A; Starodubova A; Bezsonov E; Popkova T; Orekhov A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445694
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
Sobenin IA; Chistiakov DA; Bobryshev YV; Postnov AY; Orekhov AN
Curr Pharm Des; 2013; 19(33):5942-53. PubMed ID: 23438955
[TBL] [Abstract][Full Text] [Related]
11. The alterations of mitochondrial DNA in coronary heart disease.
Hu H; Lin Y; Xu X; Lin S; Chen X; Wang S
Exp Mol Pathol; 2020 Jun; 114():104412. PubMed ID: 32113905
[TBL] [Abstract][Full Text] [Related]
12. Mutations of mitochondrial DNA in atherosclerosis and atherosclerosis-related diseases.
Sobenin IA; Zhelankin AV; Mitrofanov KY; Sinyov VV; Sazonova MA; Postnov AY; Orekhov AN
Curr Pharm Des; 2015; 21(9):1158-63. PubMed ID: 25312735
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Genome Editing: Exploring the Possible Relationship of the Atherosclerosis-Associated Mutation m.15059G>A With Defective Mitophagy.
Sukhorukov VN; Khotina VA; Kalmykov VA; Zhuravlev AD; Sinyov VV; Popov DY; Vinokurov AY; Sobenin IA; Orekhov AN
J Lipid Atheroscler; 2024 May; 13(2):166-183. PubMed ID: 38826184
[TBL] [Abstract][Full Text] [Related]
14. Parkin and PINK1 mitigate STING-induced inflammation.
Sliter DA; Martinez J; Hao L; Chen X; Sun N; Fischer TD; Burman JL; Li Y; Zhang Z; Narendra DP; Cai H; Borsche M; Klein C; Youle RJ
Nature; 2018 Sep; 561(7722):258-262. PubMed ID: 30135585
[TBL] [Abstract][Full Text] [Related]
15. From Mitochondria to Atherosclerosis: The Inflammation Path.
Suárez-Rivero JM; Pastor-Maldonado CJ; Povea-Cabello S; Álvarez-Córdoba M; Villalón-García I; Talaverón-Rey M; Suárez-Carrillo A; Munuera-Cabeza M; Sánchez-Alcázar JA
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33807807
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases.
Pérez-Treviño P; Velásquez M; García N
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165761. PubMed ID: 32169503
[TBL] [Abstract][Full Text] [Related]
17. Cellular Mechanisms of Human Atherogenesis: Focus on Chronification of Inflammation and Mitochondrial Mutations.
Markin AM; Sobenin IA; Grechko AV; Zhang D; Orekhov AN
Front Pharmacol; 2020; 11():642. PubMed ID: 32528276
[TBL] [Abstract][Full Text] [Related]
18. Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease.
Volobueva A; Grechko A; Yet SF; Sobenin I; Orekhov A
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426564
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA Mutation, Diseases, and Nutrient-Regulated Mitophagy.
Yang X; Zhang R; Nakahira K; Gu Z
Annu Rev Nutr; 2019 Aug; 39():201-226. PubMed ID: 31433742
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA, oxidants, and innate immunity.
Piantadosi CA
Free Radic Biol Med; 2020 May; 152():455-461. PubMed ID: 31958498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
